ANVS - Annovis Bio Inc Qarzning balans kapitallashuviga nisbati
Annovis Bio, Inc. (ANVS) neyronlar degradatsiyasiga qarshi kurashish uchun noyob tadqiqot va ishlanmalar (R&D) muhitini ishlab chiqmoqda. Qarz majburiyatlarining balans kapitaliga nisbati ushbu strategiyani tasdiqlaydi, bunda 0.00 qiymati metrika darajasini belgilaydi. Oqsillarni bloklash usullari uchun patent himoyasi raqobatchilar uchun kirishning sezilarli to'sig'ini yaratadi. Joriy bosqich qimmatbaho klinik sinovlarni yakunlash uchun rezervlarning kamayishi bilan xarakterlanadi.
%20Qarzning%20sof%20aktivlarga%20nisbati&width=1200&height=400&colorIndex=0&v=mvrk6wqv.ssk-7as46ww&start=20220704&end=20261028&filename=GURU_Markets_-_ANVS_-_Annovis-Bio-Inc._-_Debt-to-Net-Assets-Ratio "Annovis Bio - ANVS Qarzning balans kapitallashuviga nisbati (davr: 04.07.2022 - 28.10.2026) | 👁️GURU.Markets👁️")
Annovis Bio Inc (ANVS) - koʻrsatkichlar kesimi va moliyaviy hisobotlar
- narx va narxlar bo'yicha konsensus prognoz:
- bozor kapitallashuvi bo'yicha ma'lumotlar:
- balans kapitallashuvi bo'yicha ma'lumotlar:
- qarz va likvidlik bo'yicha ma'lumotlar:
Qarzning xususiy kapitalga nisbati Annovis Bio, Inc.|ANVS - Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi|Qisqa muddatli qarzning o'z kapitaliga nisbati Annovis Bio Corp|ANVS - Kompaniyaning jamlangan qarzi|Qarzning balans kapitallashuviga nisbati Annovis Bio Corporation|ANVS - Uzoq muddatli qarz|Kompaniyaning qisqa muddatli majburiyatlari Annovis Bio
Kompaniyaning jamlanma tahliliyoti:Annovis Bio, Inc. - ANVS
Ushbu ko'rsatkich kompaniyaning moliyaviy barqarorligi o'z kapitaliga nisbatan qarz mablag'lariga qanchalik bog'liqligini baholaydi. Umumiy qarzdorlikning kapitalga nisbati dinamikasi haddan tashqari yuqori kredit yuklamasini o'z vaqtida aniqlash imkonini beradi. Hisob-kitoblar umumiy qarzdorlikning kompaniya sof aktivlari qiymatiga nisbatiga asoslangan. Annovis Bio, Inc. (ANVS) uchun ushbu parametr kritik ahamiyatga ega, chunki tijorat mahsulotlarining yo'qligi biznesni tashqi moliyalashtirishga bog'liq qiladi. Bu yerda xavfni baholash bevosita dori vositalarining klinik sinovlari natijalari bilan bog'liqdir.
Annovis Bio, Inc. (ANVS) raqobatchilari
Qarzning balans qiymatiga nisbati BIIB (Biogen Inc.)|neurocrine.com - Balans kapitallashuviga qarzlar|Qarzning balans kapitallashuviga nisbati Regencell Bioscience Holdings Limited (RGC)|AXSM: Qarzning sof aktivlarga nisbati|Qarzning balans kapitallashuviga nisbati ACAD|Xenon Corp (XENE) - Balans qiymatiga qarzlar|VKTX (Viking Therapeutics) - Balans kapitallashuviga qarzlar|Balans kapitallashuviga qarzlar SUPN|Qarzning balans kapitallashuviga nisbati Catalyst Pharmaceuticals, Inc. CPRX|Qarzning balans qiymatiga nisbati DNLI (Denali)|HRMY - Qarzning balans kapitallashuviga nisbati|Biohaven Corp - Qarzning balans qiymatiga nisbati|AMLX (Amylyx Pharmaceuticals) - Qarzning balans kapitallashuviga nisbati|trevitherapeutics.com (TRVI) - Balans qiymatiga qarzlar|Praxis Precision Medicines, Inc. (PRAX) - Qarzning balans qiymatiga nisbati|Anavex (AVXL) - Qarzning balans kapitallashuviga nisbati|CBLL: Balans kapitallashuviga qarzlar|Sof aktivlarga qarzlar PRTA|ALEC (Alector, Inc.) - Qarzning balans kapitallashuviga nisbati|Sof aktivlarga qarzlar annexonbio.com ANNX|Qarzning balans qiymatiga nisbati Omeros|Qarzning sof aktivlarga nisbati Neurogene Inc NGNE|ACIU - Balans kapitallashuviga qarzlar|VYGR - Qarzning balans kapitallashuviga nisbati|Neumora Therapeutics - Balans kapitallashuviga qarzlar|SCLX (scilexholding.com) - Sof aktivlarga qarzlar|Qarzning balans kapitallashuviga nisbati TVGN (Tevogen Bio)|Balans qiymatiga qarzlar Alpha Cognition Corp (ACOG)|Cognition Therapeutics (CGTX) - Qarzning balans qiymatiga nisbati|Qarzning sof aktivlarga nisbati Inhibikase Pharma (IKT)|Balans kapitallashuviga qarzlar SAVA|Assertio Holdings - Sof aktivlarga qarzlar|Coya (COYA) - Qarzning balans kapitallashuviga nisbati|VTGN - Qarzning balans qiymatiga nisbati|OVID (ovidrx.com) - Balans kapitallashuviga qarzlar|Qarzning balans qiymatiga nisbati Acumen Pharmaceuticals, Inc|CRVO: Qarzning balans qiymatiga nisbati|Sof aktivlarga qarzlar Alterity Therapeutics Ltd|Balans kapitallashuviga qarzlar CLNN|Balans kapitallashuviga qarzlar PEPG (pepgen.com)|JUNS - Qarzning balans kapitallashuviga nisbati|RLMD - Qarzning balans qiymatiga nisbati|GRCE - Qarzning balans qiymatiga nisbati|AIFF: Qarzning balans kapitallashuviga nisbati|anewmeds.com - Qarzning balans kapitallashuviga nisbati|NRSN (NeuroSense Therapeutics Ltd.) - Sof aktivlarga qarzlar|Qarzning balans kapitallashuviga nisbati Reviva Pharmaceuticals Holdings (RVPH)|Qarzning balans qiymatiga nisbati MetaVia, Inc.|NeurAxis, Inc. - Balans kapitallashuviga qarzlar|Balans qiymatiga qarzlar heliusmedical.com HSDT|Qarzning balans qiymatiga nisbati PASG (Passage Bio)|Neuphoria Therapeutics, Inc. - Balans kapitallashuviga qarzlar|Qarzning balans kapitallashuviga nisbati Minerva Neurosciences Corp (NERV)|ATHA: Qarzning sof aktivlarga nisbati|Qarzning balans kapitallashuviga nisbati ADXN|Alzamend Neuro (ALZN) - Balans qiymatiga qarzlar|CYCN (Cyclerion Therapeutics Inc.) - Balans kapitallashuviga qarzlar|Balans kapitallashuviga qarzlar PTIX|Qarzning balans kapitallashuviga nisbati Pasithea Therapeutics KTTA|Qarzning balans qiymatiga nisbati CRGT (cortigent.com)|ATXI - Qarzning balans kapitallashuviga nisbati|brainstorm-cell.com - Qarzning balans qiymatiga nisbati|CARA (Cara Therapeutics) - Qarzning balans kapitallashuviga nisbati|Chromocell Therapeutics Corp (CHRO) - Balans qiymatiga qarzlar|eliemtx.com (ELYM) - Qarzning balans qiymatiga nisbati|Intra-Cellular Therapies, Inc. (ITCI) - Qarzning balans kapitallashuviga nisbati|LBPH: Balans kapitallashuviga qarzlar|Sof aktivlarga qarzlar MRNS|NKGN (NKGen Biotech) - Qarzning balans kapitallashuviga nisbati|Sof aktivlarga qarzlar NeuroBo Pharmaceuticals Inc NRBO|Qarzning balans qiymatiga nisbati Sage Therapeutics, Inc|Qarzning sof aktivlarga nisbati Synaptogenix, Inc SNPX|TRVN - Balans kapitallashuviga qarzlar|VIGL - Qarzning balans kapitallashuviga nisbati|Anew Medical - Balans kapitallashuviga qarzlar|CERE (Cerevel Therapeutics Inc) - Sof aktivlarga qarzlar